Trial intelligence / Profile preview

Clindamycin for post-operative sequelae of third molar surgery

NCT05268835Phase 4Unknown

Sponsor
Oral and Maxillofacial Surgery Clinic
Start
Feb 2020
Primary completion
Aug 2022
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of clindamycin in Infection, sponsored by Oral and Maxillofacial Surgery Clinic. Status: unknown.

02

Drugs

clindamycin
03

Conditions

Infection

Beyond the preview

Go deeper on NCT05268835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05268835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call